ZA907363B - (n-(ypsilon-glutamyl)glycyl)alanine derivatives - Google Patents

(n-(ypsilon-glutamyl)glycyl)alanine derivatives

Info

Publication number
ZA907363B
ZA907363B ZA907363A ZA907363A ZA907363B ZA 907363 B ZA907363 B ZA 907363B ZA 907363 A ZA907363 A ZA 907363A ZA 907363 A ZA907363 A ZA 907363A ZA 907363 B ZA907363 B ZA 907363B
Authority
ZA
South Africa
Prior art keywords
ypsilon
glycyl
glutamyl
alanine derivatives
alanine
Prior art date
Application number
ZA907363A
Other languages
English (en)
Inventor
Heinz Berner
Berner Heinz
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of ZA907363B publication Critical patent/ZA907363B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0215—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing natural amino acids, forming a peptide bond via their side chain functional group, e.g. epsilon-Lys, gamma-Glu
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ZA907363A 1989-09-14 1990-09-14 (n-(ypsilon-glutamyl)glycyl)alanine derivatives ZA907363B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3930739A DE3930739A1 (de) 1989-09-14 1989-09-14 Neue acylpeptide, verfahren zu ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
ZA907363B true ZA907363B (en) 1992-05-27

Family

ID=6389436

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA907363A ZA907363B (en) 1989-09-14 1990-09-14 (n-(ypsilon-glutamyl)glycyl)alanine derivatives

Country Status (14)

Country Link
EP (1) EP0417803A1 (ko)
JP (1) JPH04501862A (ko)
KR (1) KR920701239A (ko)
AU (1) AU645759B2 (ko)
CA (1) CA2035458A1 (ko)
DE (1) DE3930739A1 (ko)
HU (1) HU208156B (ko)
IE (1) IE903328A1 (ko)
IL (1) IL95662A0 (ko)
MY (1) MY106459A (ko)
NZ (1) NZ235274A (ko)
PT (1) PT95302A (ko)
WO (1) WO1991004268A1 (ko)
ZA (1) ZA907363B (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9512100D0 (en) * 1995-06-14 1995-08-09 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
EP1257541B1 (en) 2000-01-11 2008-09-03 Molecular Insight Pharmaceuticals, Inc. Polypharmacophoric agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201094B (en) * 1986-01-23 1990-09-28 Pfizer Process for producing immunostimulant acyltripeptides and pharmaceutical compositions comprising same as active ingredient

Also Published As

Publication number Publication date
KR920701239A (ko) 1992-08-11
CA2035458A1 (en) 1991-03-15
AU6359690A (en) 1991-04-18
JPH04501862A (ja) 1992-04-02
EP0417803A1 (en) 1991-03-20
IL95662A0 (en) 1991-06-30
NZ235274A (en) 1992-12-23
AU645759B2 (en) 1994-01-27
DE3930739A1 (de) 1991-03-28
PT95302A (pt) 1991-05-22
HUT56381A (en) 1991-08-28
MY106459A (en) 1995-05-30
HU208156B (en) 1993-08-30
WO1991004268A1 (en) 1991-04-04
IE903328A1 (en) 1991-04-10
HU907361D0 (en) 1991-07-29

Similar Documents

Publication Publication Date Title
GB8927255D0 (en) Peptide derivatives
GB2199829B (en) Peptide derivatives
GB8907652D0 (en) Peptide derivatives
NZ231662A (en) Dipeptide derivatives having renin-inhibitory action
EP0416373A3 (en) Amino acid derivatives
GB2226313B (en) Capsaicin derivatives
EP0244836A3 (en) Tripeptide derivatives
EP0431113A4 (en) Atrial peptide derivatives
ZA907363B (en) (n-(ypsilon-glutamyl)glycyl)alanine derivatives
GB8812343D0 (en) Amino compounds
EP0318254A3 (en) Tripeptide derivatives
GB8924612D0 (en) Peptide derivatives
GB8907902D0 (en) Peptide derivatives
PH27397A (en) Intermediate for N-(S-3-alkyl-heptanoyl) d-gamma-glutamyn-glycyl-d alanine
IE891120L (en) Peptide derivatives
IE891038L (en) Peptide derivatives
IE892472L (en) Peptide derivatives
GB8906638D0 (en) Peptide derivatives
GB9011637D0 (en) Peptide derivatives
GB8808444D0 (en) Peptide derivatives
ZA892644B (en) Peptide derivatives
GB8808277D0 (en) Peptide derivatives
GB8808441D0 (en) Peptide derivatives
GB8808528D0 (en) Peptide derivatives
ZA899285B (en) Peptide derivatives